We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Resource to support healthcare professionals to manage persistent pain in prison and secure environments.
Protocol, questionnaire and quarterly return form for the enhanced surveillance of post-herpetic neuralgia (PHN), a complication of shingles.
An analysis of self-reported chronic pain from 2017 Health Survey for England data.
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Information to assist with differentiating Lyme disease from other causes of rash, neurological or non-specific symptoms.
Find out about the long-term effects some people can have after having COVID-19.
Clinical advice on West Nile virus including symptoms, diagnosis and epidemiology.
Information for healthcare professionals on the diagnosis, prevention and treatment of hepatitis B.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
The characteristics, diagnosis, management and epidemiology of necrotising fasciitis (NF).
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.